Request Free Sample
×
GCC Biomarker Technologies Market
ID: MRFR/HC/54487-HCR
200 Pages
February 2026
GCC Biomarker Technologies Market Research Report: By Product (Consumables, Instruments), By Profiling Technology (PCR, Imaging Technology, NGS), By Application (Cancer, Infectious Disease) andBy Research Area (Genomics, Proteomics)- Forecast to 2035
Industry Developments
Recent developments in the GCC Biomarker Technologies Market indicate a notable increase in investments and collaborations aimed at enhancing diagnostic capabilities and personalized medicine. Companies like BD and Merck Group are actively participating in initiatives to advance biomarker research, thereby increasing their market presence. In terms of mergers and acquisitions, Thermo Fisher Scientific completed the acquisition of PPD, Inc. in March 2021, which has strengthened their R&D and service capabilities in the biomarker space. Abbott Laboratories, along with GenSeq, is collaborating on targeted therapies that leverage advanced biomarkers for better treatment outcomes. A surge in growth is evidenced by Roche Diagnostics, which reported significant revenue increases attributed to the rising demand for biomarker testing in oncology and infectious diseases throughout 2022. Additionally, regulatory support from Gulf Cooperation Council member states is facilitating the faster approval of biomarker-based products, which enhances market dynamism. The region's commitment to advancing healthcare infrastructure has further propelled companies like Agilent Technologies and Siemens Healthineers to invest heavily in innovative biomarker solutions, reflecting a proactive approach to meet the evolving demands of healthcare systems across the GCC.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 869.36(USD Million) |
| MARKET SIZE 2024 | 939.0(USD Million) |
| MARKET SIZE 2035 | 2347.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.685% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | BD, Merck Group, Agilent Technologies, Abbott Laboratories, Thermo Fisher Scientific, PerkinElmer, GenSeq, Qiagen, Covalent Bioscience, BioRad Laboratories, Roche Diagnostics, SAB Biotherapeutics, Siemens Healthineers, Illumina, Luminex Corporation |
| SEGMENTS COVERED | Product, Profiling Technology, Application, Research Area |
| KEY MARKET OPPORTUNITIES | Increased cancer research funding, Rising personalized medicine adoption, Advancements in diagnostic technologies, Growing focus on preventive healthcare, Enhanced regulatory support for innovations |
| KEY MARKET DYNAMICS | Rising cancer prevalence, Increasing research funding, Technological advancements, Growing personalized medicine demand, Expanding diagnostic applications |
| COUNTRIES COVERED | GCC |
Leave a Comment
FAQs
What is the projected market size of the GCC Biomarker Technologies Market in 2024?
The projected market size of the GCC Biomarker Technologies Market in 2024 is expected to be valued at 939.0 million USD.
What is the expected market value of the GCC Biomarker Technologies Market in 2035?
In 2035, the GCC Biomarker Technologies Market is expected to be valued at 2347.0 million USD.
What is the compound annual growth rate (CAGR) for the GCC Biomarker Technologies Market from 2025 to 2035?
The expected CAGR for the GCC Biomarker Technologies Market from 2025 to 2035 is 8.685%.
What are the projected market values for consumables and instruments in the GCC Biomarker Technologies Market by 2035?
By 2035, the consumables segment is projected to be valued at 1200.0 million USD, while the instruments segment is expected to reach 1147.0 million USD.
Who are the key players in the GCC Biomarker Technologies Market?
Major players in the GCC Biomarker Technologies Market include BD, Merck Group, Agilent Technologies, Abbott Laboratories, and Thermo Fisher Scientific.
How has the GCC Biomarker Technologies Market positioned itself regionally?
The GCC Biomarker Technologies Market is part of a growing healthcare sector that is experiencing rapid advancements in diagnostic and therapeutic technologies.
What are the main growth drivers for the GCC Biomarker Technologies Market?
Key growth drivers for the GCC Biomarker Technologies Market include increasing prevalence of chronic diseases and advancements in biomarker research.
What opportunities are emerging in the GCC Biomarker Technologies Market?
Emerging opportunities in the GCC Biomarker Technologies Market include the development of personalized medicine and the integration of advanced technologies.
What challenges does the GCC Biomarker Technologies Market currently face?
The challenges facing the GCC Biomarker Technologies Market include regulatory hurdles and the need for substantial investment in research and development.
What impact does the current global scenario have on the GCC Biomarker Technologies Market?
The current global scenario influences the GCC Biomarker Technologies Market by affecting supply chains and investment priorities in biotechnology.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense